Company / Operating Income per Share
Amphstar Pharmaceuticals, Inc. Operating Income per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Income per Share
$2.95
FY2025
5-year range
$1.47 / $4.27
FY2021-FY2025
Trend
-31.0%
vs FY2024
Sector context
#22 of 201
Health Care
What the data says
Amphstar Pharmaceuticals, Inc.'s operating income per share of $2.95 is higher than 89% of companies in the Health Care sector (FY2025). Declined from $4.09 to $2.95 over the past 2 years.
Based on SEC 10-K filings.
2.95 in FY2025 with a 5-year CAGR of +65.8%. Top quartile in the Health Care sector.
Declined from $4.09 to $2.95 over the past 2 years.
Health Care sector context is included.
Operating Income per Share over time
Growth rates
- 3-Year CAGR
- +9.4%
- 5-Year CAGR
- +65.8%
- 10-Year CAGR
- -
Sector benchmark
Top 11% in Health CareTop 11% of 201This company $2.95 Sector average -$28.56
▼
+110.3% above sector average
Key checks
Key Insights
- In FY2025, operating income per share decreased 31.0% year-over-year.
- Ranks #22 out of 201 companies in the Health Care sector.
- Peak operating income per share was recorded in FY2024.
- Lowest operating income per share in the period was in FY2018.
Company context
Key Data Points
- Strong profit margin: 21.8%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Income per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $2.95 | -31.0% |
| FY2024 | $4.27 | +4.4% |
| FY2023 | $4.09 | +81.7% |
| FY2022 | $2.25 | +53.1% |
| FY2021 | $1.47 | +525.7% |
| FY2020 | $0.24 | +28219.8% |
| FY2019 | -$0.00 | +99.5% |
| FY2018 | -$0.18 | -574.0% |
| FY2017 | -$0.03 | -108.1% |
| FY2016 | $0.34 | +320.2% |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026